List of investigational sleep drugs

This is a list of investigational sleep drugs, or drugs for the treatment of sleep disorders that are currently under development for clinical use but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.

Insomnia

GABAA receptor potentiators

Orexin receptor antagonists

Melatonin receptor agonists

Others/undefined

Hypersomnia/narcolepsy

Orexin receptor agonists

Monoaminergics

GHB receptor agonists

  • FT-218 (sodium oxybate controlled release) – GHB and GABAB receptor agonist
  • JZP-258 (oxybate mixed salt solution) – GHB and GABAB receptor agonist
  • JZP-386 (C-10323; deuterated sodium oxybate) – GHB and GABAB receptor agonist
  • JZP-507 (oxybate mixed salt solution) – GHB and GABAB receptor agonist

H3 receptor inverse agonists

GABAA receptor inhibitors

Others/undefined

  • TS-091 (TS-0911) – undefined mechanism of action

See also

References

  1. "Takeda". www.ox2rsparkleprogram.com. Retrieved 2019-11-15.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.